[1]
H. R. Fadhil, A. A. Al-Jumaili, and N. Al Ani, “Comparison between Reference Infliximab (Remicade) and its Biosimilar (Remsima) in Patients with Ankylosing Spondylitis: A Field-based Pharmacoeconomic Study ”, Al-Kindy Col. Med. J, vol. 19, no. 1, pp. 100–105, Apr. 2023, doi: 10.47723/kcmj.v19i1.908.